The year 2000 prompts numerous prognostications of the events to occur during the next century. Except for the Y2K problem, the year 2000 is little different in substance than 1999 or 2001. However it is useful to use the occasion to consider where we have come from and where we are going. Thinking of the future will help clarify goals, define the problems, identify priorities, and outline pathways for progress.
Opportunities and future success
'The unknown always passes for the marvelous ' Tacitus Agricola (98 AD)
I. Marvelous, indeed, how about amazing, awesome, and astounding to describe the opportunities and the expected success of molecular-genetic psychiatric research in the next century. Never before has there been such cause for optimism. Even though there are many problems and limitations, our past progress should focus our attention on the opportunities. This optimistic view can be asserted with confidence because:
(A) The progress of medicine in the past predicts the success of psychiatry in the future. The advances in other medical areas during the past 100 years (eg conquest of infectious diseases, surgical repair and pharmacological and gene therapy cures, effective prophylaxis, and restorative rehabilitation) will now occur in psychiatry during the next. For example, the gene causing cystic fibrosis has been discovered. The abnormal gene encodes an abnormal transmembrane conductance regulator which results in impaired chloride movement and susceptibility to airway colonization by pathogenic organisms. This results in a reduced life expectancy of about 30 years. It is now possible to significantly influence the underlying chloride defect in the lungs of patients with cystic fibrosis by direct transfer of a normal gene into their lungs. 1 Thus, it soon may be possible to effectively treat the fundamental abnormality of this disease and restore these patients to full health. The identification of the gene and faulty gene product causing the disease is the essential step in this success story, and it will now be possible to do this in psychiatry. Overall, the advances in medicine over the past 100 years have been miraculous. They will be even more astounding in the 21st century and psychiatry will be a part of it.
(B) The numerous genes involved in the genesis of many mental illness will be discovered. This will be accomplished through the support of the Human Genome Project with its genetic, physical, transcript, and common human sequence variant maps, and through the use of modern molecular genetic technologies. A recent example is the clear progress in understanding the molecular genetics of the dopamine system in attention deficient hyperactivity disorder, where dopamine agonists are the most effective treatment. This was recently reviewed in this journal. 2 Development and use of the new genetic maps and methods will even allow discovery of 'complex' mechanisms of genetic transmission of disease, those that are probably involved in most psychiatric diseases.
(C) New unprecedented mechanisms of pathogenesis will be discovered. The description and identification of the gene products allow the development of animal models of the disease. This, in turn, leads to the identification of the sequence of biochemical steps involved in pathogenesis. For example, the discovery of the Huntington's disease gene led to the discovery of a previously unknown gene product 'huntingtin'. It was then found that mutated huntingtin acted in the nucleus to induce apoptosis but that cell death did not correlate with the formation of intranuclear inclusions, which actually may be a protective response. 3 Thus, the discovery of the gene led to the discovery of an entirely new and previously unknown mechanism of pathogenesis. Through this type of sequence of discovery we will see invisible pathogenic mechanisms come to light. These new insights will allow many opportunities for therapeutic intervention.
(D) The new and improved understanding of pathogenesis will lead to the development of much more definitive and efficacious treatments and prevention. This is again illustrated in Huntington's disease where the discovery of the gene, the gene product and the abnormal pathophysiology led to the discovery of a possible new treatment. Caspase-1 is one of a family of cysteine proteases that are important in regulating apoptosis. In a transgenic mouse model of Huntington's disease, caspase-1 is activated, and its inhibition extends survival and delays the appearance of neuronal inclusions. 4 The molecular-genetic discoveries were essential in getting us to the point that we can now develop caspase-1 inhibitors as possible treatments of Huntington's disease. This could be an improvement on the neural transplantation methods in current use. 5 It is through molecular-genetic research that we will make the greatest advance toward the most important central goal of psychiatric research-to benefit patients, their families and society.
Thus, especially in the genetic-molecular sector of psychiatric research, the 'unknown' will be discovered to provide 'marvelous' new understanding and therapeutic advances-which will dwarf those of the 20th century, just as the advances of the 20th tower above those of the 19th century. Important as the treatment of mental illness may be, however, even more important benefits will accrue from molecular-genetic psychiatric research for humanity in general.
II.
The implications of molecular-genetic psychiatric research for the evolutionary future of mankind by the end of the 21st century are profound beyond comprehension. Cognition and emotional regulation are the central issues of continued human evolution. Molecular-genetic psychiatric research will play a critical role in this evolutionary progress in the following way:
(A) Each year there will be an exponential increase in our understanding of brain function due to the current power of molecular-genetic methods, in addition to the expanding arsenal of other methods in neuroscience. The exponential growth in available information can be seen with a medline search of Huntington's disease. Over the past 30 years, each 10-year block starting with 1969 had an average of 4, 20 and 49 articles published per year respectively. This demonstrates an average increased rate of publication of over 10 times in the 20 years between 1973-1993. Similar increases in available information can be found across all fundamental research and clinical research areas.
(B) This new information will provide for an increasingly accurate understanding of the genetic mechanisms operating at the molecular, cellular, and systems levels that regulate higher brain functions-those that subserve those most valued aspects of behavior that are so uniquely human. Even now it is possible using magnetic resonance imaging to observe increased white matter density in left but not right frontal temporal pathways that support motor and speech functions in children and adolescents. 6 Knowledge of the molecular-genetic and environmental factors controlling delays in myelination will have profound implications for our understanding of deviations in normal growth and development.
(C) The critical details for each type of gene-environment equation for an increasing number of genes and widening array of environments will be better understood. We will know which genes work best in which environments. This will allow for more precise programming and regulation of the controllable variables. For example there have been numerous attempts to increase IQ by exposing children to special environments. 7 With knowledge of the gene-environment interactions, these interventions can become much more specifically targeted and productive.
(D) By the end of the 21st century we will increasingly use a more rational form of human evolution. Genetic enhancement through gene transfer technology in humans is in its very earliest stage, and there are an enormous number of unsolved problems. 8 However, in the past and today individuals invest in future generations by selecting a mate and an environment in which to raise offspring. This can be improved upon even today with the use of in vitro fertilization to avoid passing on genetically transmitted diseases to offspring. There will be a new more rational and controllable type of evolution which will involve an iterative optimization of gene-environment interactions in order to improve the higher mental functions. Thus, molecular-genetic psychiatric research as the medical specialty that will be the most effective in elucidating and eventually modifying the biology of the human mind, will be the major portal through which ultimate human destiny will pass.
Limitations and disappointments

'Man is the measure of all things'
Protagoras (485-410 BC)
III. Man is not only the 'measure' but also the regulator and controller of all things. In addition to these extraordinary opportunities and expectations, there are limitations, many imposed by man and his society. The advances described above will be generated within but also be regulated by a social matrix. The field of psychiatry extends across the biological, psychological and social levels and one cannot be as optimistic for advances in psychiatric research at the psychological and social levels as at the molecular-genetic and biologic levels for several reasons:
(A) The science of psychiatry, similar to medicine, 9 can be viewed as a hierarchy ranging from the biological through the psychological to the social. Within the hierarchy of each of these three global levels a hierarchy of other sublevels can be seen (Table 1) . (B) Each higher level in the hierarchy has emergent properties not contained within or displayed by the subject matter of the immediately preceding level. Thus, is not possible to fully predict effects at the higher level from knowledge of the lower level. 9 (For example, it is not possible to fully predict the properties of DNA from the chemistry of nucleic acids.) (C) The description of lower levels are more exact than higher levels. The increasing complexity of emergent properties at the higher level increases the length of description-but because of the increased complexity, it is less precise and less accurate. 10 (D) The less precise and less accurate measurement of the phenomena at the higher level introduces and accommodates increased amounts of unsubstantiated authoritative opinion and individual, social, cultural and political bias into understanding (eg the blink reflex generates much less controversy than fear conditioning-let alone the huge social, cultural and political biases around intelligence). At the higher psychologic level and all of the social levels, experimentation and 'proof' or validation of theories or understanding is not possible. Thus, 'theories of the mind' and social theories only have weak correlative data for their support. This has the net effect that beliefs and social-cultural supports sustain the theory rather than objective evidence. Thus, progress in the objective scientific sense is much less at these levels.
IV.
The hierarchical gradient across psychiatry from the molecular-genetic on one end to organizational-social on the other, will define the relative rate of progress in the separate sectors. There will be powerful social interactions that will mold and ultimately determine the structure of progress. For example:
(A) Advances in the past (as would be expected in the next century), have been greatest at the lower hierarchical levels (the hard vs soft sciences). If a simple scale of 'change' during the past 100 years is applied across the spectrum from the atomic to the social, the greatest progress is in the area of the hard sciences. In Figure 1 comparing the two ends of the spectrum, there have been extraordinary advances in electronic communications but little change in most organized religions.
(B) Even though there appears to be more progress in the 'hard' as compared to the 'soft' sciences, it is difficult to find a common measurement system with which to compare the rate of change at the different levels. The emergent properties of each successively higher level preclude the use of a standardized measurement system. Small changes at the psychological and social levels can be of major importance to individuals. The measurement and comparison of 'progress' across the spectrum in Figure 1 (including the various sectors of psychiatry) is difficult at best and clearly controversial, depending on the point of view. Relatively small changes in institutional policy, service delivery, or legal-social support systems can have major effect on the lives of patients and families. However, it is important to compare the complete pharmacologically induced cure of a patient with manic depressive illness with lithium to the chronic symptomatology and social maladjustment displayed by a similar patient who receives only the best currently available psychological and social care. There are many other examples from medicine where advances in medical technology make the crucial difference. An anterior cruciate ligament tear in the knee of an athlete used to end his career even with the most advanced, expensive, compassionate, medical-psycho-social rehabilitation. Now with advances in surgical repair, a specific technical surgical procedure can be coupled to a specific medically prescribed exercise program and a complete return of function can usually be expected. (Wouldn't it be nice to attain that level of efficacy in psychiatry?) (C) The rate of progress at the psychological and social levels will be much slower because of their greater complexity. This slow rate of progress results from difficulties in experimental methodology, low precision and accuracy of measurements, and long iteration times to validate results. Ethical issues considerably add to the problems. Compared to a drug trial, a psychotherapy trial has many difficulties, including: defining the active ingredient, controlling the administration of the dose and repeating the study at another site. For example, at the social level it would be impossible to control and manipulate the important relevant variables when comparing the effectiveness of two mental health care systems in different states. At best only simple correlative measures can be obtained. Thus, the inherent structure of the phenomena at the psychologic and social levels will limit the rate of progress.
(D) Powerful social forces will limit the rate of progress at all levels. Technological advances have always generated social opposition. There are many social groups opposed to research of any type (eg animal rights movement-recently the actress Jane Seymour who plays Dr Quinn medicine woman on TV testified in support of homeopathy and was well received by a Congressional Committee on Government Reform 11 ). Even straight forward in vitro molecular biology has been inhibited in the past due to fears of generating some type of destructive molecular chain reaction. It is expected that the constraints on research will increase over time-especially with the new growth industry of 'bioethics'. Obviously ethical concerns markedly increase when moving from the biological to the psychological and social areas. This has the effect of inhibiting all but the most superficial types of research at these levels. It is clear that experimentation is impossible at the higher social levels (it would be difficult to perform a 'randomized, double blind, placebo controlled,' comparison of religion-based child rearing on intelligence). Thus, the most productive type of research, for psychiatry as a whole, controlled experimentation, will be very limited at the psychological level and impossible at the social level. Even at the biological level experimental research will have to be increasingly 'ethically justified'. Studies using terms like 'stress test' or 'challenge test' will have to be more accurately described and justified with much more attention to informed consent. V. Successful psychiatric research will grow from the scientific and economic support base of the underlying biomedical sciences. The form of progress will follow that already visible from the discovery of pathogenesis and new treatments for diseases in medicine and neurology. Some examples can illustrate important points:
(A) Our understanding the pathogenesis of brain diseases has progressed slower than that for other organs because of the lack of direct access to living human brain tissue (biopsy). In addition, the central nervous system is the most complex of all the organ systems. For example, in immunology and hematology (another system with complex physiology) living cells and tissue can be repeatedly sampled and analyzed. This allows experimentation with the cells affected in the disease, specific pathologic diagnosis of the tissue, accurate biologically based diagnosis of the patient, and assessment of the course of the disease. This has been an essential step in discovering the different diseases each with their separate and specific pathophysiologic processes (eg discovery of the different types of pathogenesis within the anemias and leukemias). Luckily, the success of research in these other medical areas can provide examples and methods for use in the study of brain diseases.
(B) Recent genetic and molecular neurobiologic findings in some neurologic and psychiatric diseases have provided important and informative lessons for psychiatry. Motor neuron diseases, 12 Parkinsonism, 13 and Alzheimer's disease 14 present many of the same impediments to research progress as do psychiatric diseases. These nervous system diseases do not permit the possibility of biopsy and only at post-mortem, when the disease has progressed to a considerable extent, is nervous tissue available. These diseases are still primarily diagnosed on clinical grounds. Even though the signs and symptoms of movement abnormalities and cognitive decline are more stable and reliable than the shifting behavioral symptoms of psychiatric diseases, considerable heterogeneity exists in all three of these conditions. [12] [13] [14] With the discovery of different genetic abnormalities in subgroups of these syndromes, a more clear understanding of the heterogeneous etiologies and possible pathogenic pathways has begun to be elucidated. With these advances, it is now possible to generate a genetic classification of neurodegenerative diseases that includes these conditions. 15 This will serve as the basis for developing new animal models of the disease which will lead to new treatments.
In Figure 2 , a general scheme of the recent progress and projected discoveries for Alzheimer's disease in comparison with manic depressive illness and schizophrenia is illustrated. It can be seen that initially, of the total number of patients within the diagnostic group, only a small percent of patients have been found to have an identified genetic etiology. However, over time, an increasing number of genetic factors will be identified that can explain pathogenesis in a larger percent of the patient population. The discovery of the gene, the gene product, and the investigation of its role in the neuropathologic tissue will provide increasingly more accurate and powerful knowledge regarding pathogenesis. For example in Alzheimer's disease, the discovery of mutations in the ␤-amyloid precursor protein has focused increased attention on the pathogenesis in this molecular pathway. This has been amplified by the finding of inherited susceptibility to Alzheimer's disease in individuals with mutations in presenilin 1 and 2 and the fact that these gene products also alter ␤-amyloid precursor protein processing. Thus, different genetic mutations that converge on a particular pathogenic pathway can be extremely informative as to the critical pathogenetic process. 17 A central point to be derived from the study of these neurologic diseases is that at the clinical, pathological, and genetic levels there is considerable heterogeneity. To the degree that genes and gene products can be identified, it will be possible to make increasingly powerful sense of what was previously an heterogeneous amalgamation of different pathogenic processes. Clearly this has considerable importance for psychiatry since in major psychiatric diseases such as schizophrenia and manic depressive illness there is even greater heterogeneity in the genetics and the pathogenic pathways than in Alzheimer's disease, Parkinsonism, and motor neuron diseases.
(C) The power and magnitude of biomedical technology and neuroscience research organization will play an increasing role in psychiatry over the coming years. Most importantly, there will be improved neuroscientific methods with underlying biomedical science validation that will be useful in investigation of psychiatric illness. The new gene knock-out technologies and the increasingly sophisticated behavioral animal models will be a major advance. 18 New discoveries in stress and neurodegeneration will provide new models for pathogenesis. 15 The recent discovery that there is neural regeneration in some parts of primate and human brain, will shed new light on possible mechanisms of behavioral plasticity. 19, 20 Powerful methodologies such as quantitative trait locus (QTL) will allow the mapping of behaviorally relevant genes that can be investigated in psychiatry. Once these genes and their products are identified their role in the biochemistry, physiology, neurophysiology, and behavior in animal models can be elucidated. All of this will add up to a much more reliable and accurate understanding of possible pathogenic mechanisms that could be operant in psychiatric patients.
(D) The development of fundamental neuroscience will play a key role in the development of psychiatric research at the clinical and therapeutic level. If it were possible to repeatedly sample the cells from the brains of affected individuals, the abnormality in the molecular, cellular, physiologic processes could be directly ascertained, and the effect of treatment could also be evaluated. Given this lack of access to brain tissue, indirect non invasive methods must be utilized. However, because of the relatively low sensitivity and specificity, compared to the methods used at the cellular level, it is not possible to understand the pathophysiologic process with these measures alone. For example, the appearance of new lesions on the MRI scan of patients with multiple sclerosis cannot identify the specific immunologic and neurodegenerative mechanisms involved in demyelination. 21 However, with the development of the fundamental neuroscience base and the utilization of appropriate animal models, considerable progress has been made in this area. It has now been found that autoantibodies against a specific myelin protein mediate target membrane damage in central nervous system demyelinating disease. 22 In this example of multiple sclerosis, use of the animal model will allow determination of the specific relationships between the appearance of lesions on MRI and the various aspects of the neuropathologic process. Analogous to completing a picture puzzle, a difficult to complete piece of the puzzle may be easier identified after the surrounding more easier placed pieces are inserted. The missing part can then be identified by extrapolating from the surrounding context. Thus, fundamental neuroscience and neuropathology will provide the context within which to elucidate the specific pathophysiology of psychiatric diseases.
VI.
The advances in molecular-genetic psychiatric research will interact with, inform, and alter, research at the psychological and social levels and it will have a profound influence on the relationship of psychiatry to society. Rather than equal increments of progress across the biological-social gradient, the next century will see interactions and modifications in the current structures of psychiatry so that a type of metamorphosis will occur. Aspects familiar today, will be slowly and incrementally modified to take a new form in the future.
(A) There will be increasing medicalization of our concepts and practices within psychiatry. Following the example of central nervous system syphilis, conditions that are initially thought to be 'functional' or 'psychogenic', will be discovered to have a medical basis. The medical and rehabilitative aspects will become more prominent and the 'functional', 'psychogenic', and 'psychodynamic' aspects will recede into the background. Psychiatric diagnoses solely based on behavior will be increasingly modified to include more meaningful and objective medical criteria. Today psychiatry is primarily a behaviorally based and treatment-oriented field. In the future, the field will increasingly be able to focus on pathophysiologic mechanisms. Thus, the descriptive behavioral aspects of psychiatry will slowly be replaced by more medically oriented schemes where the abnormal behavior will simply be viewed as a symptom of abnormal brain function. Even if, as some people would like, psychiatry is defined as only being concerned with individuals with idiopathic behavioral disorders, the fact remains that from the patients', the families', and society's point of view, individuals with behavioral abnormalities will be increasingly diagnosed and treated from the medical perspective. Even today most patients with a depression or anxiety are treated in primary care settings. The definition of 'psychiatry' and the medical economics that sustain the boundaries of the field are sociological irrelevancies when compared to what actually helps the patients.
(B) Progress in genetics and molecular biology of the central nervous system will markedly alter our concepts and our understanding of the boundaries between normal behavior and disease. Increasingly, the structural, physiologic and behavioral aspects of brain function will be organized around the genetic-molecular scheme. Much as the periodic table of the elements provides the infrastructure for the fields of chemistry and pharmacology, etc, genetics and molecular biology will provide the structure within which to view brain function and behavior. (This process is already evident in the genetic classification of primary neurodegenerative disease.
15 ) The concepts of normality and disease will be much more quantifiable and it will be increasingly possible to describe abnormal behavior in quantifiable terms, as structural and functional deviations from normal.
(C) The reductionistic scientific method will be increasingly utilized at the psychological-behavioral levels. The long history of science has demonstrated the success and robustness of this method. Today, societies, industries, economies and nations are built upon the success of the method. In the future this will even be more important. Thus, behavior and behavioral disorders, will be described in mechanistic terms where the importance of the underlying mechanisms and structures are paramount. This will force changes not only at the psychological but also at the social level. For instance, once the genes underlining an increased propensity toward lack of impulse control and violent behavior are clear, this will interact with the judicial system and force changes in definitions of freedom of choice and legal responsibility.
(D) The discovery of the new molecular and genetic information and its deposit in publicly accessible electronic data bases will profoundly influence society in general. This will be openly available, transparent, statistically meaningful scientific evidence available to everyone on a super net. There will be an increasing rate of progress as a larger percent of individuals within society access and utilize the information. It will be a major contribution to the evolution toward evidence-based medicine and hasten the end of anecdotal medicine and superficial behaviorally based and symptomatically based solipsistic psychiatry. Thus, the availability of information will support a more democratic social process in the evolution of its use. The human genome and its behavioral consequences, will be a critical worldwide resource utilized by industry, government and eventually by individuals. It is not inconceivable that within the first half of the next century, individuals will be able to obtain a profile of their own genetic composition. They will then need to deal with the medical and behavioral implications.
Summation
'In expanding the field of knowledge we but increase the horizon of ignorance ' Henry Miller, 1941 VII. Over time it is the expanded field of knowledge that sustains us. Even though we raise more questions than we answer this should be a welcome consequence of progress. The increased number of questions simply reflects the increased knowledge (increased accuracy and specificity of information) which allows new more specific questions to be articulated. In Table 2 , which briefly describes the progress of psychiatric research over time, the future will bring new knowledge of the genetic and molecular basis of disease. This in turn will support the discovery of specific pathogenic mechanisms upon which a new diagnostic system and treatment advances will be built.
When predicting the opportunities and limitations of psychiatric research in the 21st century, it is difficult to avoid the encumbrances of past definitions, the limi- It would give considerable support and encouragement to those engaged in psychiatric research to know that their work will be an important step in eventual progress. Although not every psychiatric investigator will make a meaningful and lasting contribution, most of them would like to. Overall, there is reason to be optimistic.
(A) A simple examination of the progress and events of the past century gives us considerable optimistism for the next. Increasingly, society in general and psychiatry in particular have benefited from the application of the scientific method. This is especially true in the control and management of our environment and in most areas of medicine, but to a lesser degree in understanding and treating mental illness. It would be irrational not to be optimistic for the future. However, there are limitations. In psychiatry these include difficulties in applying the biomedical model to the brain in order to explain the complexity, plasticity, and variability of behavior and its disorders. In addition, social constraints directed at human behavior markedly limit the available methods to answer important questions.
(B) The success of the biomedical model will increase and expand. The biomedical industrial complex is now an economic imperative well past the dangers of any opposing ideology. To the degree that this model can be applied to psychiatry, its success will be psychiatry's success. At the molecular genetic level there is no difference between psychiatry and the other medical areas. Thus, it is in this area that the greatest advance will occur.
(C) The medicalization of psychiatry and the consequence of mechanistic understanding of behavioral disorders will have profound implications for society. The improved understanding of the neurological basis for the abnormal behavior will force shifts in the psychological and social approaches to mental illness. Most important of all, the molecular genetic data base as it is, provides the underlying structure for understanding the neurobiology of behavior, and will play the central role in continued human evolution.
(D) One can focus on opportunities or limitations just as the same volume of water in a glass can be judged as half full or half empty. Most people would prefer the half full, since optimism provides more hope. It is of interest that a similar optimistic prognostication was made at the beginning of this century almost 100 years ago by HG Wells in his discourse. 'The Discovery of the Future'. 23 In the 100 years since this was presented, his optimism has been vindicated. Although they are not specific, many of the ideas he used to express optimism regarding the 20th century can be used today to express optimism for the 21st century. There is good reason to believe that the progress of science in the 20th century will be dwarfed by the immense progress of the 21st, and that psychiatry will be part of it. It is possible to view HG Wells' thinking 100 years ago-as it applies today: 'But is not only with pain that the world is shot-it is shot with promise. Small as our vanity and carnality make us, there has been a day of still smaller things. It is the long ascent of the past that gives the lie to our despair.' 'Why should things cease at man? Why should not this rising curve rise yet more steeply and swiftly? There are many things to suggest that we are now in a phase of rapid and unprecedented development. The conditions under which men live are changing with an ever-increasing rapidity, and, so far as our knowledge goes, no sort of creatures have every lived under changing conditions without undergoing the profoundest changes themselves'. 'In the past century there was more change in the conditions of human life than there had been in the previous thousand years. A hundred years ago inventors and investigators were rare scattered men, and now invention and inquiry are the work of an unorganized army. This century will see changes that will dwarf those of the nineteenth century, as those of the nineteenth dwarf those of the eighteenth. One can see no sign anywhere that this rush of change will be over presently, that the positivist dream of a social reconstruction and of a new static culture phase will ever be realized. Human society never has been quite static, and it will presently cease to attempt to be static.' 'Everything seems pointing to the belief that we are entering upon a progress that will go on, with an everwidening and ever more confident stride, forever. The reorganization of society that is going on now beneath the traditional appearance of things is a kinetic reorganization. We are getting into marching order. We have struck our camp forever and we are out upon the roads.'
HG Wells
A discourse delivered at the Royal Institution, 1903 
